Effects of azacitidine compared with conventional care regimens in elderly (≥ 75 years) patients with higher-risk myelodysplastic syndromes.
暂无分享,去创建一个
G. Mufti | P. Fenaux | E. Hellström-Lindberg | S. Gore | V. Santini | J. Seymour | A. List | L. Silverman | J. Backstrom | C. L. Beach | D. McKenzie